• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与电子健康记录相关联的WellCheck智能手机应用程序对2型糖尿病患者临床结局的影响：基于初级保健的前瞻性、多中心、整群随机实用临床试验研究方案。

Impact of the WellCheck smartphone app linked to electronic health records on clinical outcomes in patients with type 2 diabetes: Study protocol for primary care-based, prospective, multicenter, cluster-randomized, pragmatic clinical trials.

作者信息

Sang Hyunji, Kim Sunyoung, Hwang Jiyoung, Woo Selin, Hwang Yerin, Kim Jaewon, Lee Seohei, Yon Dong Keon, Rhee Sang Youl

机构信息

Department of Endocrinology and Metabolism, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.

Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.

出版信息

PLoS One. 2025 Aug 7;20(8):e0329003. doi: 10.1371/journal.pone.0329003. eCollection 2025.

DOI:10.1371/journal.pone.0329003
PMID:40773465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331031/
Abstract

ClinicalTrials.gov NCT06419816. Registered on 14 May 2024.

摘要

临床试验.gov标识符：NCT06419816。于2024年5月14日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/12331031/0cf44471e0ec/pone.0329003.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/12331031/2df04853473c/pone.0329003.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/12331031/0cf44471e0ec/pone.0329003.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/12331031/2df04853473c/pone.0329003.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/12331031/0cf44471e0ec/pone.0329003.g002.jpg

相似文献

1
Impact of the WellCheck smartphone app linked to electronic health records on clinical outcomes in patients with type 2 diabetes: Study protocol for primary care-based, prospective, multicenter, cluster-randomized, pragmatic clinical trials.与电子健康记录相关联的WellCheck智能手机应用程序对2型糖尿病患者临床结局的影响：基于初级保健的前瞻性、多中心、整群随机实用临床试验研究方案。
PLoS One. 2025 Aug 7;20(8):e0329003. doi: 10.1371/journal.pone.0329003. eCollection 2025.
2
Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity.移动健康（m-health）智能手机干预措施用于超重或肥胖的青少年和成年人。
Cochrane Database Syst Rev. 2024 Feb 20;2(2):CD013591. doi: 10.1002/14651858.CD013591.pub2.
3
Novel Smartphone App and Supportive Accountability for the Treatment of Childhood Disruptive Behavior Problems: Protocol for a Randomized Controlled Trial.用于治疗儿童破坏性行为问题的新型智能手机应用程序及支持性问责制：一项随机对照试验方案
JMIR Res Protoc. 2025 Mar 11;14:e67051. doi: 10.2196/67051.
4
Diabetes Telemedicine Mediterranean Diet (DiaTeleMed) Study: study protocol for a fully remote randomized clinical trial evaluating personalized dietary management in individuals with type 2 diabetes.糖尿病远程医疗地中海饮食（DiaTeleMed）研究：一项完全远程随机临床试验的研究方案，旨在评估 2 型糖尿病患者个性化饮食管理。
Trials. 2024 Jul 25;25(1):506. doi: 10.1186/s13063-024-08337-w.
5
Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double-Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker-The SMARTBINGE Trial.MyDéfi智能手机应用程序对大学生暴饮行为的影响：一项使用磷脂酰乙醇作为生物标志物的双盲多中心前瞻性全国随机对照试验方案——SMARTBINGE试验
Int J Methods Psychiatr Res. 2025 Jun;34(2):e70014. doi: 10.1002/mpr.70014.
6
Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial.以患者为中心且具有文化敏感性的2型糖尿病治疗方案对阿拉伯语、土耳其语和乌尔都语患者的有效性（ACCT2研究）：一项实用随机对照试验的方案
JMIR Res Protoc. 2025 Jun 5;14:e67319. doi: 10.2196/67319.
7
Treatment of Substance Use Disorders With a Mobile Phone App Within Rural Collaborative Care Management (Senyo Health): Protocol for a Mixed Methods Randomized Controlled Trial.农村协作式照护管理（Senyo Health）中使用手机应用程序治疗物质使用障碍：一项混合方法随机对照试验的方案
JMIR Res Protoc. 2025 Mar 26;14:e65693. doi: 10.2196/65693.
8
Technology Effects and Child Health: Wellness Impact and Social Effects (TECHWISE): Protocol for a Prospective, Observational, Real-World Study.技术影响与儿童健康：健康影响和社会效应（TECHWISE）：一项前瞻性、观察性、真实世界研究的方案
JMIR Res Protoc. 2025 Jun 19;14:e69358. doi: 10.2196/69358.
9
Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial.比较基于指南的移动健康干预与哮喘高危青少年常规护理：一项随机对照试验的方案
JMIR Res Protoc. 2025 Jul 25;14:e69903. doi: 10.2196/69903.
10
Impact of a smartphone application for appropriate antibiotic prescribing at three tertiary hospitals: an international, multicentre stepped-wedge cluster randomized trial.一款智能手机应用程序对三家三级医院合理使用抗生素的影响：一项国际多中心阶梯楔形整群随机试验
Clin Microbiol Infect. 2025 Jul;31(7):1172-1179. doi: 10.1016/j.cmi.2025.02.026. Epub 2025 Mar 1.

本文引用的文献

1
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial.外用链球菌后生元润肤剂治疗轻至中度特应性皮炎青少年及成人的疗效与安全性：一项随机、双盲、赋形剂对照试验
Allergy. 2024 Jun;79(6):1612-1616. doi: 10.1111/all.16077. Epub 2024 Mar 4.
2
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖：2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
3
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.
5. 促进积极的健康行为与福祉以改善健康结果：2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005.
4
Association between having a meal together with family and smoking: a cross-sectional nationwide survey.与家人一起用餐与吸烟的关系：一项全国性的横断面调查。
BMC Public Health. 2023 Nov 16;23(1):2261. doi: 10.1186/s12889-023-17155-9.
5
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.2023 年韩国糖尿病协会糖尿病临床实践指南。
Diabetes Metab J. 2023 Sep;47(5):575-594. doi: 10.4093/dmj.2023.0282. Epub 2023 Sep 26.
6
Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study.韩国一款与医院相关的数字健康应用程序用于控制高血压和糖尿病的真实世界证据：全国多中心研究
JMIR Form Res. 2023 Aug 21;7:e48332. doi: 10.2196/48332.
7
The effectiveness of digital health technologies for patients with diabetes mellitus: A systematic review.数字健康技术对糖尿病患者的有效性：一项系统综述。
Front Clin Diabetes Healthc. 2022 Oct 24;3:936752. doi: 10.3389/fcdhc.2022.936752. eCollection 2022.
8
The Socio-Economic Cost of Diabetes Mellitus in Korea Using National Health Insurance Claim Data, 2017.利用2017年国民健康保险理赔数据估算韩国糖尿病的社会经济成本
Healthcare (Basel). 2022 Aug 23;10(9):1601. doi: 10.3390/healthcare10091601.
9
Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method.二分类结局的群组随机对照试验且群组数量较少：个体水平分析与群组水平分析方法的比较。
BMC Med Res Methodol. 2022 Aug 12;22(1):222. doi: 10.1186/s12874-022-01699-2.
10
Diabetes Fact Sheet in Korea 2021.2021 年韩国糖尿病概况。
Diabetes Metab J. 2022 May;46(3):417-426. doi: 10.4093/dmj.2022.0106. Epub 2022 May 25.